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To evaluate the perinatal effects of a prenatal therapy based on intra-amniotic nutritional
supplementation in a rabbit model of intrauterine growth restriction (IUGR).
Methods
IUGR was surgically induced in pregnant rabbits at gestational day 25 by ligating 40–50% of
uteroplacental vessels of each gestational sac. At the same time, modified-parenteral nutrition
solution (containing glucose, amino acids and electrolytes) was injected into the amniotic sac
of nearly half of the IUGR fetuses (IUGR-T group n = 106), whereas sham injections were per-
formed in the rest of fetuses (IUGR group n = 118). A control group without IUGR induction but
sham injection was also included (n = 115). Five days after the ligation procedure, a cesarean
section was performed to evaluate fetal cardiac function, survival and birth weight.
Results
Survival was significantly improved in the IUGR fetuses that were treated with intra-amniotic
nutritional supplementation as compared to non-treated IUGR animals (survival rate: con-
trols 71% vs. IUGR 44% p = 0.003 and IUGR-T 63% vs. IUGR 44% p = 0.02), whereas, birth
weight (controls mean 43g ± SD 9 vs. IUGR 36g ± SD 9 vs. IUGR-T 35g ± SD 8, p = 0.001)
and fetal cardiac function were similar among the IUGR groups.
Conclusion
Intra-amniotic injection of a modified-parenteral nutrient solution appears to be a promising
therapy for reducing mortality among IUGR. These results provide an opportunity to develop
new intra-amniotic nutritional strategies to reach the fetus by bypassing the placental
insufficiency.
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Introduction
Intrauterine growth restriction (IUGR) is generally defined as a significant reduction in fetal
growth rate resulting in a birth weight in the lowest 10th percentile. It affects 7–10% of all
pregnancies [1] and is considered a major contributor to perinatal morbidity and mortality,
responsible for about 20–50% of perinatal deaths. It is also associated with worse short and
long-term outcomes as increased prevalence of intrapartum distress, neonatal complications
[2], suboptimal neurodevelopment [3,4] and cardiovascular disease [5,6]. Currently, there is
no effective nutritional therapy to improve fetal growth or to ameliorate the adverse outcomes
associated with IUGR [7–10]. Thus, the assessment of fetal well-being and timely delivery
remain as the main management strategy, outweighing fetal injury/stillbirth versus the risks of
iatrogenic preterm delivery.
Placental insufficiency is the most common cause of IUGR where the nutrient transport to
the fetus is compromised [11]. To date, several studies in humans [10,12–15] and animals [16–
18] testing diverse therapies administrated to the mother have failed to demonstrate a substan-
tial improvement in fetal outcomes related to placental insufficiency. The lack of effectiveness
of these therapies that are only aimed at the mothers could most probably be explained by a
failure of nutrient transport between the mother and the fetus in the presence of the placental
disease [19–22], therefore the administrated therapies cannot cross the placenta and reach the
fetus. Direct nutrient supply to the fetus could theoretically overcome this problem by bypass-
ing the placenta. However, previous studies that attempted to supply carbohydrates, growth
factors or amino acid mixtures through trans-amniotic catheter insertion or direct fetal injec-
tions led to inconclusive results [23–30]. Moreover, most studies used a single nutrient
approach with an invasive trans-amniotic placement of a catheter for several days. We hypoth-
esized now that the administration of a complete nutrient composition (combining essential
nutrients such as glucose, amino acids and electrolytes) in a single intra-amniotic injection
could improve the outcomes of IUGR. Thus, we planned to administrate this complete nutri-
ent composition therapy by intra-amniotic injections based on the fetus capacity of swallowing
amniotic fluid, by which essential nutrients delivered intra-amniotically would reach the gas-
trointestinal tract and be absorbed [31,32], potentially compensating the nutrient deficiency
caused by placental insufficiency.
In this study, we used a rabbit model of placental insufficiency to test the hypothesis that
intra-amniotic nutrient delivery would improve the perinatal outcome of IUGR fetuses, by
analyzing survival, birth weight and fetal cardiac remodeling.
Material and methods
Animals and experimental procedure
The study has been reported according to the ARRIVE guidelines[33] for reporting the in vivo
experiments. Animal handling and all procedures were performed in accordance with applica-
ble regulations and guidelines and with the approval of the Animal Experimental Ethics Com-
mittee of the University of Barcelona (Permit no: 250/15) All efforts were made to reduce both
animal suffering and the number of animals used.
Thirty-eight time-mated 24 months old New Zealand White pregnant rabbits were pro-
vided by a certified breeder at 18th day of gestation (full term is approximately 31 days). Dams
were housed in separate cages on a reversed 12/12 h light cycle, with free access to water and
standard chow. At 25th day of gestation, IUGR was induced surgically by uteroplacental vessel
ligation and intra-amniotic injections were performed. At 30th day of gestation,an abdominal
incision was made and the uterine horns were exteriorized to perform fetal echocardiography
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in a subgroup of fetuses. Subsequently, fetuses were delivered by cesarean section. Experimen-
tal design and timeline are shown in Fig 1 and the description of all the procedures are detailed
in the following sections.
Rabbit model of IUGR and therapy administration
On gestational day 25, an abdominal midline laparotomy was performed and both uterine
horns were exteriorized under endovenous anesthesia of Ketamine (Ketolar1 50mg/ml, Pfi-
zer, 10 mg/kg) and Xylazine (Rompun1 2%, Bayer, 3mg/kg). Gestational sacs of both horns
were counted and numbered, and each fetus was identified according to the fetal position
within the bicornuate uterus. Prior to surgery, each uterine horn was randomly allocated to a
group (control, IUGR or IUGR-T) based on a computer generated randomization number
sequence. As each dam has two uterine horns, in order to obtain three experimental groups
(control, IUGR and UGR-T), horns of each dam was assigned to a paired combination of these
groups, resulting in three combinations (control and IUGR, control and IUGR-T, or IUGR
and IUGR-T). Based on the ligation and nutrient injection, the experimental groups were cre-
ated: Control (no IUGR induction and sham injection, n = 115), IUGR (IUGR induction and
Fig 1. Experimental design. In pregnant rabbit at 25th day of gestation, IUGR was surgically induced by uteroplacental vessel ligation and intra-amniotic injections were
performed. Control fetuses did not undergo vessel ligature and they had sham injection. IUGR fetuses underwent uteroplacental vessel ligature and sham injection. and
finally IUGR-T fetuses underwent uteroplacental vessel ligature and therapy administration which is intra-amniotic injection of 300 μl of modified-parenteral nutrient
solution. At 30th day of gestation, cesarean section was performed and uterine horns were exteriorized to perform fetal echocardiography in a subgroup of fetuses from
each experimental group. The fetuses were then taken out for survival assessment and biometric measurements and then sacrificed for tissue sampling. Black arrows and
yellow circles indicate ligated uteroplacental vessels of fetal sacs in the uterine horn, yellow arrow indicates intra-amniotic injection to the fetal sac and red arrow
indicates the ultrasound transducer.
https://doi.org/10.1371/journal.pone.0193240.g001
Nutritional intra-amniotic therapy increases survival in a rabbit model of fetal growth restriction
PLOS ONE | https://doi.org/10.1371/journal.pone.0193240 February 21, 2018 3 / 13
sham injection, n = 118) and IUGR-T (IUGR induction and therapy administration, n = 106).
IUGR was surgically induced by ligation of 40–50% of the uteroplacental vessels of the
assigned gestational sacs [34]. In addition, 300 μl of modified-parenteral nutrition solution
(see Table 1 for composition details: a complete mixed composition containing glucose, amino
acids and electrolytes, but excluding lipids, based on previous evidence of respiratory insuffi-
ciency in fetuses who received trans-amniotic lipid emulsion [26]), was injected to the amni-
otic sac of the IUGR-T fetuses via a 25G needle (B.Braun Sterican1). The IUGR and control
groups received needle puncture without administrating any substance to the amniotic sac
(sham injection) (Fig 1). Administration of Buprenorphine (Buprex injectable, 0.3 mg/ml;
Schering-Ploug, Madrid, Spain) was used as a post-operative medication: The dams received a
single dosage of Buprenorphine (0.01–0.05mg/kg), administrated subcutaneously after the
induction of IUGR and administrated orally diluted in the water during the first 48 hours after
the operation (0.03ml /5kg/8h).
































The solution has an osmolarity of 1.085 mOsm/L
https://doi.org/10.1371/journal.pone.0193240.t001
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Fetal echocardiography and cesarean section
At 30 days of pregnancy, an abdominal midline laparotomy was performed and uterine horns
exteriorized under endovenous anesthesia of Ketamine (Ketolar1 50mg / ml, Pfizer) 10 mg/
kg and Xylazine (Rompun1 2%, Bayer) 3mg/kg. After that, fetal echocardiography was per-
formed in a subgroup of fetuses using vivid q ultrasound equipment (GE Healthcare, Little
Chalfont Buckinghamshire, UK) with i12L-RS linear transducer, placed directly on each exte-
riorized gestational sac. Cardiac area, thoracic area, ventricular base-to-apex length and trans-
verse diameters, and septal myocardial wall thickness were measured in end-diastole from a
2D image. Then, cardio-thoracic ratio was calculated by dividing cardiac area per thoracic
area. Ventricular sphericity indexes were calculated as base-to-apex length divided by trans-
verse diameter. Heart rate was also measured using Doppler applied on the left outflow tract.
Immediately after echocardiography, all live and stillborn fetuses were obtained by uterine
horn incision and weighted. Dams were sacrificed by endovenous overdose of sodium pento-
barbital (200 mg/kg), immediately after fetal extraction. All living newborns were sacrificed by
immediate decapitation. Survival rate was determined by the ratio of live fetuses at the time of
the cesarean section to all viable fetuses at the time of the ligature procedure. Intestine samples
were collected after delivery for subsequent analysis.
Sampling and analysis of fetal intestine
After sacrificing the fetuses, one-centimeter tissue sample was collected from the proximal
small intestine and fixed with 4% paraformaldehyde in PBS for 24 h at 4˚C. Fixed intestinal
samples were embedded in paraffin to obtain 5μm sections to be stained with hematoxylin and
eosin. Histology images were acquired using a microscope (Leica, Bannockburn, IL) and soft-
ware (Leica Application Suite, version 3.4). Quantification of intestine diameter, villus height
and muscular and sub-mucosal layer thickness was performed using Image J software (http://
rsbweb.nih.gov/ij) in order to evaluate intestinal structure.
Statistical analysis
The STATA14.0 package was used for statistical analyses. Qualitative variables were compared
by Pearson’s Chi Square test. Normal distribution of quantitative variables was assessed by
Shapiro-Wilk test. Normally-distributed variables were expressed as mean and standard devia-
tion and analyzed by one-way ANOVA followed by a Bonferroni’s Multiple Comparison post
hoc test. Non-normal distributed parameters were shown as median and interquartile range
and compared by non-parametric Kruskal-Wallis. Statistical significance was declared at
p<0.05.
Results
Intra-amniotic nutrient supplementation increases IUGR survival with no
improvement in birth weight
A total of 339 fetuses were obtained (115 control, 106 IUGR and 108 IUGR-T fetuses, respec-
tively) from 38 dams. Of these 339 fetuses, 201 were alive at the day 30 of cesarean section (82
controls, 52 IUGR and 67 IUGR-T). The mean litter size was 11.4 ± 2.3.
Non-treated IUGR fetuses presented a significantly lower survival rate (IUGR 44% vs. con-
trol 71% p = 0.003) and lower birth weight as compared to controls (Figs 2A and 3). However,
under therapy, IUGR-T fetuses showed a significantly higher rate of survival (IUGR-T 63% vs.
IUGR 44%, p = 0.02) despite the birth weight was similar to non-treated IUGR (Figs 2A and
3). A further analysis associated with fetuses’ uterine position revealed that birth weight of
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control fetuses was significantly higher as compared to both IUGR and IUGR-T groups inde-
pendently from the uterine position (Fig 4). As expected, fetuses in extreme positions (ovarian
and cervical ends) had higher survival rate as compared to the fetuses in intermediate positions
(control 78% versus 68%; IUGR 50% versus 41%; IUGR-T 66% versus 62%, Fig 5) as compared
to the fetuses in the intermediate positions. This observation was detected in all the experimen-
tal groups. For both positions, control fetuses had significantly higher birth weight than IUGR
and IUGR-T fetuses, while birth weight of the latter two groups did not differ from each other
(Fig 4).
An analysis performed for a subgroup of fetuses that weighed less than 30 grams (which
correspond to the 10th centile of normally distributed weight at birth [3,6,34–36]) revealed that
a significantly higher proportion of IUGR-T animals with that weight were alive compared to
IUGR animals (Fig 2B).
Intra-amniotic nutrient supplementation does not compensate for fetal
cardiac adaptation
Fetal echocardiography revealed similar cardiac alterations in both IUGR and IUGR-T fetuses
with larger hearts, thicker myocardial walls and a more spherical left ventricle as compared to
controls (Table 2).
Intra-amniotic nutrient supplementation ameliorates IUGR intestine
structural changes
Regardless of the absence of any positive change in fetal cardiac functions and birth weight
among IUGR-T treated fetuses, the notable improvement in the survival rate in this group ver-
sus IUGR fetuses may suggest that the nutritional supplementation administrated was able to
reach circulation in IUGR fetuses, very likely through swallowing and intestinal absorption.
Actually, performed histological analyses of the small intestine (Fig 6) provide some evidence
Fig 2. Survival rate. Survival rate among controls, intrauterine growth restricted cases (IUGR) or IUGR cases with therapy (IUGR-T) in the overall population (Control:
82 surviving out of 115; IUGR: 52 surviving out of 118; IUGR-T: 67 surviving out of 106) (A) and among newborns weighing 20-30g (IUGR: 14 surviving out of 23;
IUGR-T: 22 surviving out of 25) (B).  p<0.05 as compared to controls; # p<0.05 as compared to IUGR.
https://doi.org/10.1371/journal.pone.0193240.g002
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for that hypothesis; revealing shorter villus height and a less organized structure of the absor-
bent surface in IUGR than IUGR-T fetuses, which appears to be partially ameliorated in
IUGR-T intestines (Fig 6).
Discussion
Our results support intra-amniotic injection of nutrients as a promising therapy for reducing
mortality among IUGR, regardless of no apparent effects on birth weight. These results open
opportunities for intra-amniotic nutritional strategies to reach the fetus bypassing the
placenta.
The striking finding of our study is the improvement of survival rate in IUGR fetuses
receiving intra-amniotic nutritional supplementation. Our results demonstrate that intra-
amniotic injection of a modified-parenteral nutrition notably reduces mortality in an animal
model of placental insufficiency. In contrast, intra-amniotic nutrition was not able to amelio-
rate birth weight or fetal cardiac adaptation. Several studies in the early 90s also attempted to
supply nutrients in the amniotic cavity with dissimilar results. Mulvihill et al. demonstrated a
Fig 3. Birth weight. Scatter dot plot of birth weight among controls, intrauterine growth restricted cases (IUGR) or IUGR cases with therapy (IUGR-T). The horizontal
line is the mean. p<0.05 as compared to controls.
https://doi.org/10.1371/journal.pone.0193240.g003
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positive effect on fetal growth with similar mortality by 5-days intra-amniotic continuous infu-
sion of bovine amniotic fluid or dextrose plus amino acids in rabbits [27,28]. In contrast, Flake
et al. could not demonstrate any improvement in birth weight by 6-days continuous amniotic
infusion of dextrose, dextrose-amino acid mixture or lipids in a ‘natural runting’ IUGR rabbit
model [26]. Actually, the infusion of lipid emulsion resulted in chronic lipid aspiration and
further growth retardation. Phillips et al. used 4-days continuous intra-amniotic infusion of
Fig 4. Birth weight in relation to uterine position. Birth weight among controls, intrauterine growth restricted cases without (IUGR) or with therapy (IUGR-T) in
fetuses that are in extreme positions (ovarian and cervical ends) (Control n = 32; IUGR n = 20; IUGR-T n = 25) (A) and intermediate positions (Control n = 50; IUGR
n = 32; IUGR-T n = 42) (B),  p<0.05.
https://doi.org/10.1371/journal.pone.0193240.g004
Fig 5. Survival rate in relation to uterine position. Survival rate among controls, intrauterine growth restricted cases without (IUGR) or with therapy (IUGR-T) in
fetuses that are in extreme positions (Control: 32 surviving out of 41; IUGR 20 surviving out of 40; IUGR-T 25 surviving out of 38) and intermediate positions (Control:
50 surviving out of 74; IUGR: 32 surviving out of 78; IUGR-T: 42 surviving out of 68) positions.  p<0.05 as compared to controls; # p<0.05 as compared to IUGR.
https://doi.org/10.1371/journal.pone.0193240.g005
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radioactive glucose and proline to demonstrate fetal nutrients absorption but failed to show
changes in survival and birth weight [30]. Buchmiller et al. showed unchanged body weight
and mortality after 4-days intra-amniotic infusion of galactose [37]. Finally, in the present
study a combination of carbohydrates, amino acids and electrolytes were administrated by a
single amniotic injection in a rabbit model of uteroplacental vessel ligation showing improve-
ment of survival despı̀te no improvement in birth weight. Overall, the contradictory results
from different studies could be explained by differences in therapy duration (single adminis-
tration vs. 4–6 days of continuous infusion) and timing, type of nutrients administered
(including or not including electrolytes), IUGR models (naturally vs. uteroplacental ligation)
and sample size. Nutrient administration by a single injection might associate less mortality
than a more invasive procedure such as a catheter insertion required for continuous infusion
during several days. While intra-amniotic lipids seem deleterious, carbohydrates and amino
acids appear essential for fetal development and growth. In addition, electrolytes such as







Cardio-thoracic area 0.35 ± 0.03 0.40 ± 0.06 0.39 ± 0.06
Myocardial wall thickness† 0.17 ± 1.01 0.21 ± 0.05 0.20 ± 0.07
LV sphericity index 1.43 ± 0.05 1.32 ± 0.05 1.22 ± 0.06
RV sphericity index 1.22 ± 0.17 1.26 ± 0.21 1.19 ± 0.09
Values are mean ± standard deviation.
p<0.05 as compared to the control group.
†Myocardial wall thickness normalized by cardiac area. LV, left ventricular; RV, right ventricular.
https://doi.org/10.1371/journal.pone.0193240.t002
Fig 6. Histological analysis of the small intestine. Hematoxylin and eosin stained sections from controls (A),
intrauterine growth restricted cases (IUGR, B) or IUGR cases with therapy (IUGR-T, C), illustrating similar villus
height in controls and IUGR-T, with shorter height in IUGR. (a,b,c) 200 x magnification of stained sections, scale bars
correspond to 100μm. sb denotes sub-mucosa and m mucosa. (D) Intestinal morphometric measurements of controls,
intrauterine growth restricted cases without (IUGR) or with therapy (IUGR-T).
https://doi.org/10.1371/journal.pone.0193240.g006
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potassium, calcium, magnesium could also be essential for fetal survival by regulating nutrient
uptake [38]. The use of large sample size in a severe IUGR model with high perinatal mortality
enabled us to demonstrate an improvement in survival rate among IUGR-T fetuses. We specu-
late that the specific mixture of glucose, amino acids and electrolytes (without lipids) adminis-
trated by a single amniotic injection in the present study is enough to improve the fetal
nutritional status subsequently increasing survival. Our data also suggest that nutritional status
seems to be more critical than hypoxia for survival. A possible explanation for the lack of birth
weight improvement in IUGR-T fetuses could be that survival of mainly the more severely
restricted animals (fetuses with birth weight between 20 and 30 grams that would otherwise
have died) pulled down the mean birth weight. Another potential explanation is that single
administration of nutrients could only partially counteract the effect of placental insufficiency.
Placental insufficiency is usually associated with a complex pathophysiologic adaptation lead-
ing to nutrient and oxygen restriction to the fetus, but also increased placental resistance
inducing pressure overload to the fetal heart (that has to pump against a more resistant pla-
centa). Most likely, intra-amniotic injection of modified-parenteral nutrition permits to ame-
liorate the critical fetal nutritional deficiency, but not the fetal hypoxia or pressure overload
(that would explain the maintained low birth weight and fetal cardiac remodeling).
Uterine horn position seems to be a relevant factor for birthweight in rabbit model. Bautista
and colleagues [39] demonstrated that animals closer to the extremities of the uterine horn
had higher weight and survival compared to the animals in intermediate position. In correla-
tion with the results reported by Bautista et al., we have also found that fetuses in the extreme
positions had significantly higher birth weight than the fetuses in the intermediate position in
all groups (Fig 4). Moreover, the birth weight difference of the fetuses between subgroups was
significant which is consistent with our results of the whole population (control fetuses had
significantly higher birth weight than IUGR and IUGR-T fetuses, while the birth weight was
similar in IUGR and IUGR-T), independently of the position. We have also observed a non-
significant trend for higher survival rate in extreme positions (Fig 5) which is also consistent
with previously reported data [39]. Taken together, the position analysis indicates that the
therapy is effective to counteract IUGR, independent of the uterine position.
The present study also showed that IUGR induction by uteroplacental vessels ligation had a
negative impact on the gut structure that seems to be ameliorated by intra-amniotic injection
of nutrients. Similarly, previous studies exhibited improved small intestine growth in IUGR
animals by esophageal infusions of nutrients to fetal rabbit and fetal sheep [28,29], demonstrat-
ing the nutritive value of fetal swallowing in fetal intestine. In addition, previous data suggest
that intra-amniotic infusion of nutrients swallowed by the fetus are transported through the
gastrointestinal tract, absorbed and concreted into fetal tissues [30], suggesting an active trans-
port of nutrients in the fetal small intestine. Taken together, our findings correlate with these
studies and provide additional support for the hypothesis that intra-amniotic infusion of nutri-
ents has a trophic effect in fetal small intestine which might provide an additional explanation
for the increase in survival with IUGR-T fetuses in our study.
We acknowledge gender issues as one potential limitation for our study as sex of the ani-
mals could not be determined at the time of birth, therefore it was not possible to analyze dif-
ferences in survival rate and birth weight by gender. As it was stated in the study of Tarrade
et al.[40], sexual dimorphism can be often observed in rabbits in the HFD model. Further stud-
ies are needed to assess the difference between male and female birth weight and survival rate
in the nutritional intra-amniotic therapy model. We also acknowledge limited information on
the weights of placenta of newborn rabbits, therefore we could not calculate the fetal-placental
weight ratio (F:P). Future studies are warranted to examine the impact of intra-amniotic thera-
pies in placental development.
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In conclusion, our study demonstrates that intra-amniotic nutrient supplementation
increases survival rates of IUGR fetuses remarkably, particularly among those more severe
IUGR animals. The use of a mixed nutritional solution containing essential carbohydrates,
amino acids and electrolytes seems as an appropriate approach for reducing the mortality in
IUGR. The findings from our study could be considered as a potential advance to fetal inter-
vention of IUGR. This would raise the possibility of therapeutic strategies to improve survival
particularly in those more severely restricted fetuses. Future studies are warranted to evaluate
different fetal nutritional supplementation in IUGR outcomes in order to find the optimal
mode, dose and timing of administration and nutritional composition.
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nent cardiac sarcomere changes in a rabbit model of intrauterine growth restriction. PLoS One. 2014; 9:
1–8. https://doi.org/10.1371/journal.pone.0113067 PMID: 25402351
7. Gulmezoglu AM, Hofmeyr GJ. Plasma volume expansion for suspected impaired fetal growth.
Cochrane database Syst Rev. ENGLAND; 2000; CD000167. https://doi.org/10.1002/14651858.
CD000167 PMID: 10796166
8. Gulmezoglu AM, Hofmeyr GJ. Betamimetics for suspected impaired fetal growth. Cochrane database
Syst Rev. England; 2001; CD000036. https://doi.org/10.1002/14651858.CD000036 PMID: 11687064
9. Laurin J, Persson PH. The effect of bedrest in hospital on fetal outcome in pregnancies complicated by
intra-uterine growth retardation. Acta Obstet Gynecol Scand. SWEDEN; 1987; 66: 407–411. PMID:
3321864
10. Say L, Gulmezoglu AM, Hofmeyr GJ. Maternal nutrient supplementation for suspected impaired fetal
growth. Cochrane database Syst Rev. England; 2003; CD000148. https://doi.org/10.1002/14651858.
CD000148 PMID: 12535390
11. Wu G, Bazer FW, Cudd TA, Meininger CJ, Spencer TE. Maternal Nutrition and Fetal Development. J
Nutr. 2004; 2169–2172. PMID: 15333699
12. Makrides M, Crowther C a., Gibson R a., Gibson RS, Skeaff CM. Efficacy and tolerability of low-dose
iron supplements during pregnancy: A randomized controlled trial. Am J Clin Nutr. 2003; 78: 145–153.
PMID: 12816784
13. Simmer K, Thompson RP. Maternal zinc and intrauterine growth retardation. Clin Sci (Lond).
ENGLAND; 1985; 68: 395–399.
14. Merialdi M, Carroli G, Villar J, Abalos E, Gülmezoglu a M, Kulier R, et al. Nutritional interventions during
pregnancy for the prevention or treatment of impaired fetal growth: an overview of randomized con-
trolled trials. J Nutr. 2003; 133: 1626S–1631S. Available: http://www.ncbi.nlm.nih.gov/pubmed/
12730476 PMID: 12730476
15. Liberato SC, Singh G, Mulholland K. Effects of protein energy supplementation during pregnancy on
fetal growth: a review of the literature focusing on contextual factors. Food Nutr Res. 2013; 57.
16. Somm E, Larvaron P, van de Looij Y, Toulotte A, Chatagner A, Faure M, et al. Protective effects of
maternal nutritional supplementation with lactoferrin on growth and brain metabolism. Pediatr Res.
2013; 75: 51–61. https://doi.org/10.1038/pr.2013.199 PMID: 24213624
17. Lin G, Wang X, Wu G, Feng C, Zhou H, Li D, et al. Improving amino acid nutrition to prevent intrauterine
growth restriction in mammals. Amino Acids. 2014; 46: 1605–23. https://doi.org/10.1007/s00726-014-
1725-z PMID: 24658999
18. Lassala A, Bazer FW, Cudd TA, Datta S, Keisler DH, Satterfield MC, et al. Parenteral Administration of
L -Arginine Prevents Fetal Growth Restriction in Undernourished Ewes. J Nutr. 2010; 140: 1242–1248.
https://doi.org/10.3945/jn.110.125658 PMID: 20505020
19. Marconi AM, Paolini CL. Nutrient Transport Across the Intrauterine Growth-Restricted Placenta. Semin
Perinatol. 2008; 32: 178–181. https://doi.org/10.1053/j.semperi.2008.02.007 PMID: 18482618
20. Cetin I, Alvino G, Radaelli T, Pardi G. Fetal nutrition: a review. Acta Paediatr Suppl. 2005; 94: 7–13.
https://doi.org/10.1080/08035320510043709 PMID: 16214758
21. Wallace JM, Bourke D a, Aitken RP, Milne JS, Hay WW. Placental glucose transport in growth-
restricted pregnancies induced by overnourishing adolescent sheep. J Physiol. 2003; 547: 85–94.
https://doi.org/10.1113/jphysiol.2002.023333 PMID: 12562948
22. Regnault TRH, Friedman JE, Wilkening RB, Anthony R V, Hay WW. Fetoplacental transport and utiliza-
tion of amino acids in IUGR—a review. Placenta. 2005; 26 Suppl A: S52–62. https://doi.org/10.1016/j.
placenta.2005.01.003 PMID: 15837069
23. Harrison MR, Villa RL. Trans-amniotic fetal feeding. I. Development of an animal model: continuous
amniotic infusion in rabbits. J Pediatr Surg. 1982; 17: 376–80. Available: http://www.ncbi.nlm.nih.gov/
pubmed/6811718 PMID: 6811718
24. Fowden a L, Hughes P, Comline RS. The effects of insulin on the growth rate of the sheep fetus during
late gestation. Q J Exp Physiol. 1989; 74: 703–14. Available: http://www.ncbi.nlm.nih.gov/pubmed/
2687925 PMID: 2687925
25. Skarsgard ED, Amii L a, Dimmitt R a, Sakamoto G, Brindle ME, Moss RL. Fetal therapy with rhIGF-1 in
a rabbit model of intrauterine growth retardation. J Surg Res. 2001; 99: 142–6. https://doi.org/10.1006/
jsre.2001.6120 PMID: 11421616
26. Flake AW, Villa-Troyer RL, Adzick NS, Harrison MR. Transamniotic Fetal Feeding III. The Effect of
Nutrient Infusion on Fetal Growth Retardation. J Pediatr Surg. 1986; 21: 481–484. PMID: 3088253
27. Mulvihill SJ, Albert A, Synn A, Fonkalsrud EW. In utero supplemental fetal feeding in an animal model:
effects on fetal growth and development. Surgery. United States; 1985; 98: 500–505.
Nutritional intra-amniotic therapy increases survival in a rabbit model of fetal growth restriction
PLOS ONE | https://doi.org/10.1371/journal.pone.0193240 February 21, 2018 12 / 13
28. Mulvihill SJ, Stone MM, Fonkalsrud EW, Debas HT. Trophic effect of amniotic fluid on fetal gastrointesti-
nal development. J Surg Res. 1986; 40: 291–296. https://doi.org/10.1016/0022-4804(86)90189-7
PMID: 3702386
29. Trahair J, Sangild P. Fetal organ growth in response to oesophageal infusion of amniotic fluid, colos-
trum, milk or gastrin-releasing peptide: a study in fetal sheep. Reprod Fertil Dev. 2000; 12: 87–95.
PMID: 11194563
30. Phillips JD, Fonkalsrud EW, Mirzayan A, Kim CS, Kieu A, Zeng H, et al. Uptake and distribution of con-
tinuously infused intraamniotic nutrients in fetal rabbits. J Pediatr Surg. 1991; 26: 374–380. https://doi.
org/10.1016/0022-3468(91)90982-Y PMID: 2056396
31. Pritchard J. Fetal Swallowing and Amniotic Fluid Volume. Obstet Gynecol. 1966; 606–610. PMID:
5332288
32. Orlic D. Fetal Rat Intestinal Absorption of Horseradish Peroxidase from Swallowed Amniotic Fluid. J
Cell Biol. 1973; 56: 106–119. PMID: 4118449
33. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting:
The arrive guidelines for reporting animal research. Animals. 2013; 4: 35–44. https://doi.org/10.3390/
ani4010035
34. Eixarch E, Figueras F, Hernández-Andrade E, Crispi F, Nadal A, Torre I, et al. An experimental model
of fetal growth restriction based on selective ligature of uteroplacental vessels in the pregnant rabbit.
Fetal Diagn Ther. 2009; 26: 203–11. https://doi.org/10.1159/000264063 PMID: 19955698
35. Eixarch E, Hernandez-Andrade E, Crispi F, Illa M, Torre I, Figueras F, et al. Impact on fetal mortality
and cardiovascular Doppler of selective ligature of uteroplacental vessels compared with undernutrition
in a rabbit model of intrauterine growth restriction. Placenta. Elsevier Ltd; 2011; 32: 304–309. https://
doi.org/10.1016/j.placenta.2011.01.014 PMID: 21334065
36. Illa M, Brito V, Pla L, Eixarch E, Arbat-Plana A, Batallé D, et al. Early Environmental Enrichment
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